CARCINOMA IN SITU OF THE BLADDER
Clinical trials for CARCINOMA IN SITU OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA IN SITU OF THE BLADDER trials appear
Sign up with your email to follow new studies for CARCINOMA IN SITU OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine-like therapy aims to keep bladder cancer from coming back
Disease control Recruiting nowThis study tests whether adding an experimental treatment (V940) to standard BCG therapy helps people with high-risk non-muscle invasive bladder cancer live longer without their cancer returning. About 308 adults will be randomly assigned to get either V940 plus BCG or BCG alone.…
Matched conditions: CARCINOMA IN SITU OF THE BLADDER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Bladder cancer patients may avoid surgery with new drug combo
Disease control Recruiting nowThis phase 2 trial is testing whether two chemotherapy drugs, gemcitabine and docetaxel, given directly into the bladder can treat high-risk bladder cancer that did not respond to standard BCG therapy. About 174 adults will receive weekly treatments for 6 weeks, then monthly for …
Matched conditions: CARCINOMA IN SITU OF THE BLADDER
Phase: PHASE2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC